2nd Edition

Handbook of Harnessing Biomaterials in Nanomedicine Preparation, Toxicity, and Applications

Edited By Dan Peer Copyright 2021
    560 Pages 35 Color & 31 B/W Illustrations
    by Jenny Stanford Publishing

    560 Pages 35 Color & 31 B/W Illustrations
    by Jenny Stanford Publishing

    Nanomedicine has emerged as a novel field in medicine integrating nano-scale technologies with materials sciences, chemistry and biology. The medical application of nanotechnology has the potential to revolutionize diagnosis and therapy and bring this new field from a notion into reality while impacting the lives of millions around the world. This second edition compiles and details the latest cutting-edge research in science and medicine from the interdisciplinary standpoint who are currently revolutionizing drug delivery techniques through the development of nanomedicines. Edited by Dan Peer, a prominent bio-nanotechnologiest, this book will attract anyone involved materials sciences, chemistry, biology and medicine that would like to design applications in the medical field of nanotechnology towards cancer therapy, inflammation, viral infection, imaging and toxicity.

    1. Biomaterial-based particulate drug carriers, Rimona Margalit
    2. Single -Chain Polymer, Iraida Loinaz
    3. Polyethelene Glycol Polyester, Laird Forrest
    4. Recent progress in Polymer, Ronit Satchi-Fainaro
    5. Polysaccharides as nanomaterials for Therapeutics, Dan Peer
    6. RNAi as new class of Nanomedicines, Derek M. Dykxhoorn
    7. Novel RNA interference (RNAi-based Nanomedicines, Priti Kumar
    8. Barcodes, Avi Schroder
    9. Detection and description of, Alan Packard
    10. Imaging, Paolo Decuzzi
    11. Image based high content analysis, Miguel Weil
    12. Albumin, Kenneth Howard
    13. Wrong Resemblance, Thomas Vorup-Jensen
    14. Complement activation, Janos Szebeni
    15. Doxil, Y. Barenholz


    Dan Peer is a is a Full Professor and the Director of the Laboratory of Precision NanoMedicine at Tel Aviv University (TAU). From 2016, he is the Chair of Tel Aviv University Cancer Biology Research Center; the biggest Cancer Center in Israel that includes 17 affiliated hospitals and from 2017, the Founding and Managing Director of SPARK Tel Aviv, Center for Translational Medicine at TAU. From Oct. 2020 he will become the Vice President for Research and Development of Tel Aviv University.